Data from the 2013 EU Safety and Effectiveness Clinical Trial: Venous Leg Ulcer (VLU) Study is available at slide 10 of the FTT announcement issued 3 Mar 2014. The results have no doubt also been presented in subsequent FTT presentations.
Find it by searching ASX 2014 FTT announcements https://www.asx.com.au/asx/statistics/announcements.do
There was no placebo, 36% of 45 patients healed 100%, 67% had greater than 50% wound reduction.
FTT Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held